SpectraCure AB (publ) (SPEC.ST)
SEK 3.59
(15.81%)
SEK 3.59
(15.81%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 144.83 Million SEK | -10.83% |
| 2022 | 162.41 Million SEK | -14.75% |
| 2021 | 190.51 Million SEK | -9.51% |
| 2020 | 210.53 Million SEK | 110.14% |
| 2019 | 100.19 Million SEK | 45.31% |
| 2018 | 68.94 Million SEK | 368.68% |
| 2017 | 14.71 Million SEK | -48.86% |
| 2016 | 28.76 Million SEK | 104.1% |
| 2015 | 14.09 Million SEK | 153.77% |
| 2014 | 5.55 Million SEK | -15.44% |
| 2013 | 6.56 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 141.28 Million SEK | -2.45% |
| 2024 Q2 | 131.81 Million SEK | -6.7% |
| 2023 Q1 | 157.16 Million SEK | -3.23% |
| 2023 FY | 144.83 Million SEK | -10.83% |
| 2023 Q4 | 144.83 Million SEK | -2.64% |
| 2023 Q3 | 148.76 Million SEK | -3.35% |
| 2023 Q2 | 153.92 Million SEK | -2.06% |
| 2022 Q1 | 185 Million SEK | -2.89% |
| 2022 FY | 162.41 Million SEK | -14.75% |
| 2022 Q4 | 162.41 Million SEK | -3.76% |
| 2022 Q3 | 168.77 Million SEK | -3.98% |
| 2022 Q2 | 175.76 Million SEK | -5.0% |
| 2021 FY | 190.51 Million SEK | -9.51% |
| 2021 Q1 | 210.09 Million SEK | -0.21% |
| 2021 Q2 | 202.97 Million SEK | -3.39% |
| 2021 Q3 | 197.3 Million SEK | -2.79% |
| 2021 Q4 | 190.51 Million SEK | -3.44% |
| 2020 Q1 | 98.12 Million SEK | -2.06% |
| 2020 Q2 | 232.59 Million SEK | 137.05% |
| 2020 Q3 | 212.83 Million SEK | -8.5% |
| 2020 Q4 | 210.53 Million SEK | -1.08% |
| 2020 FY | 210.53 Million SEK | 110.14% |
| 2019 Q2 | 73.65 Million SEK | 7.51% |
| 2019 Q1 | 68.5 Million SEK | -0.64% |
| 2019 FY | 100.19 Million SEK | 45.31% |
| 2019 Q4 | 100.19 Million SEK | 47.0% |
| 2019 Q3 | 68.15 Million SEK | -7.46% |
| 2018 Q2 | 23.47 Million SEK | -9.91% |
| 2018 FY | 68.94 Million SEK | 368.68% |
| 2018 Q4 | 68.94 Million SEK | 234.03% |
| 2018 Q3 | 20.64 Million SEK | -12.08% |
| 2018 Q1 | 26.06 Million SEK | 77.16% |
| 2017 Q3 | 17.82 Million SEK | -8.65% |
| 2017 Q1 | 21.28 Million SEK | -26.01% |
| 2017 Q2 | 19.5 Million SEK | -8.34% |
| 2017 Q4 | 14.71 Million SEK | -17.46% |
| 2017 FY | 14.71 Million SEK | -48.86% |
| 2016 Q1 | 12.45 Million SEK | -11.59% |
| 2016 FY | 28.76 Million SEK | 104.1% |
| 2016 Q3 | 9.11 Million SEK | -15.59% |
| 2016 Q4 | 28.76 Million SEK | 215.72% |
| 2016 Q2 | 10.79 Million SEK | -13.38% |
| 2015 Q3 | 10.62 Million SEK | -42.44% |
| 2015 Q4 | 14.09 Million SEK | 32.63% |
| 2015 Q1 | 5.3 Million SEK | -4.56% |
| 2015 Q2 | 18.46 Million SEK | 248.33% |
| 2015 FY | 14.09 Million SEK | 153.77% |
| 2014 FY | 5.55 Million SEK | -15.44% |
| 2014 Q4 | 5.55 Million SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2013 FY | 6.56 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -130.319% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 95.594% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 95.594% |
| Arcoma AB | 81.96 Million SEK | -76.709% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 78.791% |
| BICO Group AB (publ) | 10.19 Billion SEK | 98.58% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 80.819% |
| CellaVision AB (publ) | 928.71 Million SEK | 84.405% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -150.903% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -559.671% |
| C-Rad AB (publ) | 404 Million SEK | 64.15% |
| Duearity AB (publ) | 15.14 Million SEK | -856.379% |
| Dignitana AB (publ) | 44.83 Million SEK | -223.067% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -38.863% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.737% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -41.111% |
| Iconovo AB (publ) | 128.07 Million SEK | -13.081% |
| Integrum AB (publ) | 164.85 Million SEK | 12.147% |
| Luxbright AB (publ) | 40.68 Million SEK | -255.974% |
| Mentice AB (publ) | 322.52 Million SEK | 55.094% |
| OssDsign AB (publ) | 356.38 Million SEK | 59.361% |
| Paxman AB (publ) | 167.12 Million SEK | 13.338% |
| Promimic AB (publ) | 92.87 Million SEK | -55.945% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -270.932% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -125.128% |
| ScandiDos AB (publ) | 81.47 Million SEK | -77.769% |
| Sectra AB (publ) | 3.21 Billion SEK | 95.489% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 85.717% |
| Senzime AB (publ) | 433.54 Million SEK | 66.593% |
| Stille AB | 804.89 Million SEK | 82.006% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 99.116% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 93.403% |